PATENT CLAIM ANALYSIS

Application Number: 16093376
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "342000"]

Abstract:
Disclosed is a compound for treating fibrosis-related diseases, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Claim (Index 13):
The compound, pharmaceutically acceptable salt and tautomer thereof of  claim 12 , wherein ring A is selected from phenyl, pyridinyl, pyrazinyl, pyrimidyl, pyridaziny, pyrryl, imidazolyl, pyrazolyl, furyl, thienyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, truazolyl, benzothienyl.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16325626', '16326976', '16066852', '16096848', '15750704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8213858098443906
- 35 USC 102 Novelty (BERT): 0.5523020580253356
- Combined Prediction Score: 0.7944774346624851
- Mean Citation Score: 391.3555060000001
- Max Citation Score: 429.8432
- Similarity Product: 314.68785229415886

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test